Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Find Roth IRA index funds with the lowest fees to keep more of your returns. Compare expense ratios and pick a cost-efficient fund for long-term growth.
27,085 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Bitcoin rebounded from a sub-$62,000 dip while Pi Network’s PI slumped to new lows. The split move underscores ongoin...
Oil traders are watching a rumored china’s ‘secret’ billion barrel reserve as prices hold steady amid mixed Chinese i...
A high-profile insider move by Pinterest’s leadership drew attention from investors. This deep dive explains what the...
Bagel prices are climbing in 2026, but the bagel remains a daily staple and a symbol of immigrant business resilience...
As of mid-February 2026, state regulators hold a steady advantage in the legal battle over prediction markets, even w...
XRP traders are watching a ripple price alert: last signal that historically preceded a major rally. Analysts caution...
Mortgage lenders accelerate the shift to digital promissory notes as funding timelines tighten. The trend signals eno...
Krispy Kreme’s stock jumped after a quarterly report showed potential signs of a turnaround, even as revenue declined...
Household bills are climbing again amid a web of factors from aging infrastructure to data-center demand. This report...
Pet insurance stocks are among the year's standout performers in the broader insurance space. This review highlights ...
Solana nears a critical price threshold near the mid-$90s, sparking renewed bets on a rebound. Derivatives flow point...